Alx Oncology Holdings ALXO
NASDAQ ALXO
$1.25 -0.05 (-3.85%)
As of: Oct 2, 2026 · 11:57 AM EDT

Alx Oncology Holdings (ALXO) Long-Term Debt Repayments (2021 - 2026)

Updated

Alx Oncology Holdings' Long-Term Debt Repayments came in at $1.3 million for Q2 2026, up 450.2% from $237,000 a year earlier but down 0.1% from the prior quarter.

Analysis

Alx Oncology Holdings (ALXO) Long-Term Debt Repayments (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Alx Oncology Holdings reported Long-Term Debt Repayments of $2.99 million, up 206.1% year-over-year; for FY2025, it came in at $929,000, up 12.3% from FY2024.

  • Long-Term Debt Repayments carries a four-year compound annual growth rate of 34.8% (FY2021 to FY2025).
  • Going back by year, Long-Term Debt Repayments was $827,000 in FY2024 (+113.1%), $388,000 in FY2023 (unchanged), $388,000 in FY2022 (+38.1%) and $281,000 in FY2021.
  • The five-year range for quarterly Long-Term Debt Repayments is $35,000 (Q2 2022) to $1.31 million (Q1 2026).
  • Year-over-year, Long-Term Debt Repayments has increased for three consecutive quarters, with growth averaging 155.4% over the last eight quarters.
  • The fastest year-over-year change in Long-Term Debt Repayments over five years came in Q2 2026 (growth of 450.2%), and the weakest in Q3 2025 (a decline of 55.3%).
  • Business Quant data shows ALXO's Long-Term Debt Repayments at $1.31 million (Q1 2026), $225,000 (Q4 2025) and $160,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 2.00 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.45 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 17.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Alx Oncology Holdings 192.12 Mn 192.12 Mn - 1.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.30 Mn
Mar 31, 2026 1.31 Mn
Dec 31, 2025 225,000.00
Sep 30, 2025 160,000.00
Jun 30, 2025 237,000.00
Mar 31, 2025 307,000.00
Dec 31, 2024 76,000.00
Sep 30, 2024 358,000.00
Jun 30, 2024 218,000.00
Mar 31, 2024 175,000.00
Dec 31, 2023 63,000.00
Sep 30, 2023 111,000.00
Jun 30, 2023 107,000.00
Mar 31, 2023 107,000.00
Dec 31, 2022 107,000.00
Sep 30, 2022 141,000.00
Jun 30, 2022 35,000.00
Mar 31, 2022 105,000.00
Dec 31, 2021 104,000.00
Sep 30, 2021 104,000.00
API Access

Alx Oncology Holdings Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ALXO&period=max&api_key=YOUR_API_KEY